RESEARCH APPLICATIONS
GPR54 receptor binding and activation assays
— Hypothalamic-pituitary-gonadal (HPG) axis signalling studies
— Gene expression and transcription factor analysis
— Analytical reference standard for method validation
— In vitro cell-based signalling pathway studies
SPECIFICATIONS
— Molecular Weight: 1,302.52 g/mol
— Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂
— Storage: Store lyophilized at -20°C. Reconstituted peptide at 4°C.
Related Products
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
GLOW Blend is a proprietary research peptide combination containing multiple research-grade peptides in a single lyophilised preparation. Formulated for laboratory convenience in peptide research applications. Verified at >=98% purity via HPLC. For in-vitro laboratory research only.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
Retatrutide (LY-3437943) is a synthetic peptide with triple agonist activity at GIP, GLP-1, and glucagon receptors. Molecular formula: C_(219)H_(338)N_(60)O_(67)S. Supplied as lyophilised powder, verified at >=98% purity via HPLC. For in-vitro laboratory research only.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
TB500 is a synthetic peptide fragment representing the 17-amino acid active region (Ac-SDKP) of Thymosin Beta-4, a 43-amino acid naturally occurring protein. Molecular weight: approximately 4963 g/mol. Thymosin Beta-4 is an actin-sequestering protein present in most cell types. Supplied as lyophilised powder, verified at >=98% purity via HPLC. For in-vitro laboratory research only.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human gastric juice protein. Molecular weight: 1419.53 g/mol. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Supplied as lyophilised powder, verified at >=98% purity via HPLC. For in-vitro laboratory research only.